However, it is not clear how important is the JNK activation in the maintenance of Ph+ B-ALL and whether the JNK inhibition could cooperate with BCR-ABL inhibitors in treating Ph+ B-ALL. Here, MAPK8 is linked to acute lymphoblastic leukemia.